Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruzengxiao capsule for mammary hyperplasia (liver depression and phlegm coagulation pattern)
CTR20191989Phase 2Completed
- Sponsor
- Heilongjiang Tianlong Pharmaceutical
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ruzengxiao in breast hyperplasia, sponsored by Heilongjiang Tianlong Pharmaceutical. Started Oct 2019; status: completed.
02
Drugs
Ruzengxiao
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on CTR20191989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191989.